Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-30

Clinical Trial Update: Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing salvage moderate hypofractionated versus ultrahypofractionated radiotherapy for biochemical recurrence after radical prostatect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Samsung Medical Center | Conditions: Prostate Cancer | Phase 3 | Status: RECRUITING